Dr. Bela Patel, MD

Dr. Patel practices at Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System.

Dr. Patel's NPI, 1750309076, was assigned on July 17, 2006. Dr. Patel graduated from McGovern Medical School in 1993. Dr. Patel holds Texas license J6647.

Dr. Patel's primary practice is Memorial Hermann-Texas Medical Center, at 6411 Fannin, Houston, TX 77030 in Harris County. The practice phone is (713) 704-3700.

Dr. Patel's primary practice is Memorial Hermann-Texas Medical Center in Houston, Texas, part of Memorial Hermann Health System. Dr. Patel is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is UT Physicians. Dmand AI also links Dr. Patel to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 4 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Patel is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Patel is licensed in Texas.

CMS data shows 56 Medicare services from Dr. Patel across 2 procedure codes in 2024, all of them office visits, for 35 Medicare patients. Medicare paid $4,618 for them. Every service was in an office.

CMS counts 35 Medicare patients who saw Dr. Patel in 2024. The largest group is 75 to 84, with 16 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 73, with 62% women.

In 2024, Dr. Patel wrote 597 Medicare Part D claims for 57 patients. 63% of them were for generic drugs. CMS names the drug for 489 of them, across 20 drugs with 11 or more claims each, at $2,812,438 in total drug cost. In 2023, CMS named 528 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Patel for performance year 2024, reported as part of a group. Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links 63 papers to Dr. Patel, published from 2011 to 2025. 2022 was the busiest year, with 9. The most frequent topics are COVID-19, SARS-CoV-2 and Intensive Care Units. Dr. Patel has published most often in Ann Am Thorac Soc. Dr. Patel's most frequent co-authors are Yuriko Fukuta, MD, Barry Ross Meisenberg, MD and James Harvey Paxton, MD.

Dmand AI links Dr. Patel to 18 clinical trials, 8 of them phase 2 studies. 3 are still active or recruiting. Conditions studied include Pulmonary Arterial Hypertension, COVID-19 and Hypertension, Pulmonary. United Therapeutics sponsors the most, 4.

CMS Open Payments shows 78 general payments to Dr. Patel from 13 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 44% of the total. Actelion Pharmaceuticals US, Inc. paid the most, $9,743.

Dr. Patel graduated from McGovern Medical School in 1993. Dr. Patel is a member of ACCP and ATS.

Dr. Patel is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.